Studies find that nearly half of people who start a GLP-1 stop due to cost or side effects like nausea, vomiting, or diarrhea
Tirzepatide targets two receptors, GLP-1 and GIP, and pushes weight loss to about 20-22%
The prescribing information for these medications contains a boxed warning regarding the potential risk of thyroid C-cell tumors, a rare form of thyroid cancer
GLP-1s also silence drug noise the intrusive thoughts about using and the magnetic pull toward an addictive substance that dominates the minds of people with addiction, says Dr Ziyad Al-Aly, Professor of Medicine at Washington University, US, and lead author of the study
For many people, they finally provide something that feels differentmore control, more consistency, and a sense of possibility that may not have been there before
We'll also discuss how bistroMD can enhance both your short-term and long-term success